Skip to main content
. 2020 Oct 29;48(10):0300060520966538. doi: 10.1177/0300060520966538

Table 2.

Demographic data according to dose of gonadotropins administered.

Characteristic Total dose of gonadotropins
P-value
<450 IU (n = 232) 450–599 IU (n = 216) 600–749 IU (n = 188) ≥750 IU (n = 294)
Female age (years) 32.5 (30.0–35.0) 34.0 (31.0–36.0) 33.0 (31.0–36.0) 33.0 (30.0–36.0) 0.124
FSH (IU/L) 7.10 (6.10–8.00) 6.90 (5.85–8.55) 7.10 (6.10–8.25) 6.80 (5.80–8.40) 0.772
LH (IU/L) 4.40 (3.50–5.80) 4.40 (3.30–5.75) 4.50 (3.30–6.10) 4.20 (3.30–6.90) 0.882
E2 (pmol/mL) 146.0 (108.0–182.5) 151.0 (106.0–181.8) 132.5 (107.3–177.0) 125.5 (84.0–180.3) 0.001
Type of infertility
 Primary 148 (63.8%) 135 (62.5%) 108 (57.4%) 153 (52.0%) 0.026
 Secondary 84 (36.2%) 81 (37.5%) 80 (42.6%) 141 (48.0%)
Cause of infertility
 Unexplained 150 (64.7%) 142 (65.7%) 125 (66.5%) 153 (52.0%) 0.001
 PCOS 82 (35.3%) 74 (34.3%) 63 (33.5%) 141 (48.0%)
Duration of infertility (years) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 0.325
No. of preovulatory follicles 1.0 (1.0–2.0) 1.0 (1.0–2.0) 1.0 (1.0–2.0) 1.0 (1.0–2.0) 0.004
EMT (mm) 8.00 (7.00–9.30) 8.70 (7.13–10.00) 9.00 (7.70–10.28) 9.10 (8.00–10.83) <0.001

Results are expressed as median with interquartile range or number (percentile). FSH, follicle-stimulating hormone; LH, luteal hormone; E2, estradiol; PCOS, polycystic ovarian syndrome; EMT, endometrial thickness.